BioSpace News Archive

The MEDICREA® Group, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD® ASI proprietary software platform, services and technologies, announced that the United States Patent Office has recently issued the Company additional key patents related to the UNiD ASI proprietary technology platform.

Vizient announces that it is collaborating with Civica Rx to help reduce the impact of drug shortages.

Québec Inc., has received a notification letter from Health Canada indicating that all requested license amendments have been approved.

Policy Statement Reviewed & Supported by the American Camp Association

Choom Niagara, the first legal, adult use cannabis store to operate in Niagara Falls, ON has produced over $49,000 in sales on its opening day.

In CLL/SLL Patients in the DUO Study, Duvelisib Treatment Rapidly Increased Lymphocytes and Resulted in Shrinkage of Lymph Nodes, With 86% of Patients Achieving a Lymph Node Response

Special Meeting of Stockholders Adjourned Until July 12, 2019

It is the most common form of cancer in women between the age of 25 and 29, followed by breast cancer, and the most common in men between the age of 30 and 35, ahead of lung and colon cancer.

Bio-Pharma veteran Claude LeDuc to replace Dr. Brent Norton as President and Chief Executive Officer

Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation